Characteristic | n (%) |
---|---|
Years since diagnosis | Mean (range, median) |
1.33 (0.03–9, 0.5) | |
ECOG Status1 (Self-reported) | |
0 | 2 (10%) |
1 | 11 (52%) |
2 | 8 (38%) |
Diagnosis | |
Ovarian | 13 (62%) |
Primary Peritoneal | 4 (19%) |
Ovarian and Fallopian Tube | 3 (14%) |
Fallopian Tube | 1 (5%) |
Cytoreductive surgery | |
Yes | 13 (62%) |
No | 8 (38%) |
Treatment (Tx) status at the time of interview | |
1st line Tx | 9 (43%) |
Receiving Tx for a recurrence | 6 (29%) |
Tx naive | 3 (14%) |
Received Tx within past 12 months | 3 (14%) |
Neoadjuvant chemotherapy | |
No | 11 (52%) |
Yes | 10 (48%) |